The stock price of Renovaro Inc (NASDAQ: RENB) has surged by 5.87 when compared to previous closing price of 0.34, but the company has seen a -4.23% decline in its stock price over the last five trading sessions. globenewswire.com reported 2025-06-03 that Expanded IP Portfolio Enhances Data Harmonization and Predictive Analytics Capabilities for High-Growth Biomedical Markets LOS ANGELES, June 03, 2025 (GLOBE NEWSWIRE) — Renovaro Inc. (NASDAQ: RENB), a clinical-stage precision medicine company, today announced that its subsidiary BioSymetrics has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a new patent application titled “Methods, Systems, and Frameworks for Unbiased Data in Drug Discovery Predictions” (Application No. 18/058,752).
Is It Worth Investing in Renovaro Inc (NASDAQ: RENB) Right Now?
RENB has 36-month beta value of 0.53.
The public float for RENB is 83.77M, and currently, short sellers hold a 5.60% ratio of that float. The average trading volume of RENB on June 20, 2025 was 3.11M shares.
RENB’s Market Performance
RENB’s stock has seen a -4.23% decrease for the week, with a 25.28% rise in the past month and a -47.44% fall in the past quarter. The volatility ratio for the week is 4.31%, and the volatility levels for the past 30 days are at 6.58% for Renovaro Inc The simple moving average for the last 20 days is 9.21% for RENB stock, with a simple moving average of -44.88% for the last 200 days.
RENB Trading at 7.43% from the 50-Day Moving Average
After a stumble in the market that brought RENB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.69% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RENB starting from William Anderson Wittekind, who sale 1,114 shares at the price of $1.30 back on Jul 29 ’24. After this action, William Anderson Wittekind now owns 840,319 shares of Renovaro Inc, valued at $1,448 using the latest closing price.
William Anderson Wittekind, the 10% Owner of Renovaro Inc, sale 16,362 shares at $1.46 during a trade that took place back on Jul 17 ’24, which means that William Anderson Wittekind is holding 841,433 shares at $23,889 based on the most recent closing price.
Stock Fundamentals for RENB
Current profitability levels for the company are sitting at:
- -436.21 for the present operating margin
- 0.5 for the gross margin
The net margin for Renovaro Inc stands at -369.28. The total capital return value is set at -0.89. Equity return is now at value -67.13, with -50.56 for asset returns.
Based on Renovaro Inc (RENB), the company’s capital structure generated 0.07 points at debt to capital in total, while cash flow to debt ratio is standing at 1674609.08. The debt to equity ratio resting at 0.08. The interest coverage ratio of the stock is -180.39.
Currently, EBITDA for the company is -81.52 million with net debt to EBITDA at -0.06. When we switch over and look at the enterprise to sales, we see a ratio of 383.77. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.13.
Conclusion
To put it simply, Renovaro Inc (RENB) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
